Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CDRH 2022: Shuren Says COVID-19 Left Agency ‘Battle-Scarred’ But Also Wiser

The Agency’s Annual Report Discussed Its Top Challenges And Accomplishments For The Year That Was

Executive Summary

The US Food and Drug Administration’s device center released its annual report, noting the challenges posed by monkeypox on top of the ongoing COVID-19 pandemic. The report also cites what the center sees as its accomplishments for the year.

You may also be interested in...

Have You Heard? Hearing Aids Are Now Available Over The Counter

US consumers have OTC access a year after FDA proposed category. While OTC category is limited to devices designed for mild to moderate hearing loss and not more severe hearing impairment, it covers vast majority of consumers with hearing loss.

FDA Device User Fees Climb For FY2023

The US Food and Drug Administration has announced higher user fees for FY2023, with most fees jumping about 18% while 510(k) fees saw an eye-popping 56% increase.

FDA Updates COVID-19 Test Policy; Shifts Focus From EUAs

As part of a policy revamp, the US FDA is encouraging COVID-19 test developers to pursue traditional premarket review pathways rather than emergency use authorizations.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts